Lerna Biopharma Pte. Ltd (Lerna Bio) proudly announces the unveiling of its pioneering liver regeneration drug candidate, LR1, at The Liver Meeting in Boston organized by American Association for...

EpicentRx, Inc. ("EpicentRx"), a clinical-stage biotechnology company with two therapeutic platforms that address cancer and inflammatory diseases, has been selected for oral and poster...

Qualys, Inc. (NASDAQ: QLYS), a pioneer and leading provider of disruptive cloud-based IT, security and compliance solutions, today announced that management will participate in a fireside chat and...

The Luxury Kitchen Appliance Brand Brings its Challenger Mindset & Commitment to Disruptive Progress Back to Dallas BENTON HARBOR, Mich., Nov. 6, 2023 /PRNewswire/ -- JennAir brand returns to...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Jefferies 2023 London Healthcare...

Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment SEOUL, South Korea, Nov. 6,...

Actimab-A can target CD33 positive immune suppressing myeloid derived suppressor cells and restore T cell proliferation and effector response Solid tumor MDSC infiltration and uptake of Actimab-A...

As Cilium becomes first CNCF cloud native networking category project to graduate, Isovalent Enterprise for Cilium 1.14 accelerates platform teams' ability to adopt and scale the platform that's...

Oral presentation highlights the resolving of inflammation and superior homing to bone marrow of CXCR4-enriched T regulatory cells. Poster presentation includes safety and efficacy data from phase...

With resounding success and unwavering resilience, the 134th China Import and Export Fair ("Canton Fair", "the Fair") drew to a close on November 4 in Guangzhou, with the online platform operating...